Streptococcus B swab SIGMA GBS™

vaginalanalwith transport medium

320,000 babies develop invasive Strep B infection. 90,000 babies under 3 months die from Strep B infection. (GBSS.org.uk). Group B Strep infection is preventable and should be detected sooner before the baby is born. ∑-GBS™ is an invention from MWE, which is a swab based device. It enables direct collection and rapid processing of specimens screening for Streptocccus agalactiae. It has an enrichment broth, which means after a few hours of incubation, the specimen is ready for direct plating on chromogenic agar for the detection and identification of Streptocccus agalactiae. The product includes a 2ml vial of Lim broth (for the enrichment of Group B Streptococcus) and a swab which can be snapped into the vial. Recommended applications Screening for Streptocccus agalactiae is normally performed in late pregnancy. The swab is used to collect specimen(s) in normal way from vagina and/or rectum. Features Lim Broth Medium Enrichment of specimens ready for direct plating on chromogenic agar Interfering bacteria inhibited, including E. coli Liquid format compatible with automated processing platforms Benefits Simpler processing and faster turnaround Convenient Snap ‘n’ Cap format for easy specimen handling Convenient format for screening for Group B Streptococcus colonisation